5-41870266-T-TC
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_001364300.2(OXCT1):c.-524dupG variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.011 in 1,608,674 control chromosomes in the GnomAD database, including 853 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.014 ( 100 hom., cov: 32)
Exomes 𝑓: 0.011 ( 753 hom. )
Consequence
OXCT1
NM_001364300.2 5_prime_UTR
NM_001364300.2 5_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.667
Genes affected
OXCT1 (HGNC:8527): (3-oxoacid CoA-transferase 1) This gene encodes a member of the 3-oxoacid CoA-transferase gene family. The encoded protein is a homodimeric mitochondrial matrix enzyme that plays a central role in extrahepatic ketone body catabolism by catalyzing the reversible transfer of coenzyme A from succinyl-CoA to acetoacetate. Mutations in this gene are associated with succinyl CoA:3-oxoacid CoA transferase deficiency. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 5-41870266-T-TC is Benign according to our data. Variant chr5-41870266-T-TC is described in ClinVar as [Likely_benign]. Clinvar id is 93008.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.0722 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OXCT1 | NM_000436.4 | c.78+14dupG | intron_variant | ENST00000196371.10 | NP_000427.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OXCT1 | ENST00000196371.10 | c.78+14dupG | intron_variant | 1 | NM_000436.4 | ENSP00000196371.5 |
Frequencies
GnomAD3 genomes AF: 0.0141 AC: 2140AN: 152016Hom.: 96 Cov.: 32
GnomAD3 genomes
AF:
AC:
2140
AN:
152016
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0313 AC: 7843AN: 250232Hom.: 455 AF XY: 0.0296 AC XY: 4008AN XY: 135414
GnomAD3 exomes
AF:
AC:
7843
AN:
250232
Hom.:
AF XY:
AC XY:
4008
AN XY:
135414
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0107 AC: 15539AN: 1456540Hom.: 753 Cov.: 29 AF XY: 0.0120 AC XY: 8729AN XY: 725076
GnomAD4 exome
AF:
AC:
15539
AN:
1456540
Hom.:
Cov.:
29
AF XY:
AC XY:
8729
AN XY:
725076
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0142 AC: 2160AN: 152134Hom.: 100 Cov.: 32 AF XY: 0.0175 AC XY: 1298AN XY: 74362
GnomAD4 genome
AF:
AC:
2160
AN:
152134
Hom.:
Cov.:
32
AF XY:
AC XY:
1298
AN XY:
74362
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
174
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Uncertain:1Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Uncertain:1Benign:1
Uncertain significance, no assertion criteria provided | clinical testing | Eurofins Ntd Llc (ga) | Oct 02, 2012 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 20, 2021 | - - |
Succinyl-CoA acetoacetate transferase deficiency Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at